Atomera Incorporated: FY2023 Form 10-K Summary
Business Context and Reporting Period
Atomera develops and licenses Mears Silicon Technology (MST), a proprietary silicon thin-film process intended to improve semiconductor transistor performance, power efficiency, reliability and scaling. The company does not manufacture or sell integrated circuits directly; its intended model is to earn upfront license fees, engineering revenue and royalties on MST-enabled wafers or devices.
The filing covers the fiscal year ended December 31, 2023, with comparative results for 2022. The company is an early-stage, single-segment business with limited revenue and 21 full-time employees. As of February 15, 2024, 26.62 million common shares were outstanding.
Financial Results and Key Metrics
| Metric | 2023 | 2022 | Change |
|---|---|---|---|
| Revenue | $550,000 | $382,000 | +44% |
| Gross profit | $522,000 | $301,000 | +73% |
| Gross margin | 94.9% | 78.8% | Improved |
| Operating expenses | $21.2 million | $17.8 million | +19% |
| Loss from operations | $(20.7) million | $(17.5) million | Worsened |
| Net loss | $(19.8) million | $(17.4) million | Worsened |
| Net loss per share | $(0.80) | $(0.75) | Worsened |
| Cash used in operations | $(14.6) million | $(12.5) million | Higher use |
Revenue in 2023 consisted entirely of a manufacturing-license milestone related to STMicroelectronics. Research and development expense was $12.5 million, up 25%, primarily due to higher outsourced development and wafer-processing costs, employee costs, stock-based compensation and technical consulting. General and administrative expense increased 10% to $7.1 million, while selling and marketing expense increased 19% to $1.6 million.
Interest income increased to $723,000 from $340,000, and the company recorded $283,000 of accretion income from short-term investments. Stock-based compensation totaled $4.0 million in 2023, compared with $3.4 million in 2022.
Liquidity, Cash Flow and Capital Structure
- Cash, cash equivalents and short-term investments were approximately $19.5 million at December 31, 2023, including $12.6 million of cash and $6.9 million of short-term investments.
- Working capital was approximately $16.6 million; total assets were $24.0 million and stockholders’ equity was $18.2 million.
- Operating cash burn increased to $14.6 million from $12.5 million.
- Investing cash outflow was $6.8 million, primarily reflecting purchases of short-term available-for-sale securities.
- Financing cash inflow was $12.7 million, primarily from the ATM offering, partially offset by $918,000 of financing-lease principal payments.
- Financing-lease liabilities totaled approximately $3.1 million, including $1.3 million current and $1.8 million long term. The filing does not identify conventional bank debt.
- The company sold approximately 1.8 million shares through its ATM program for $13.5 million of net proceeds during 2023. Approximately $29.8 million remained available under the facility at year-end.
- Management believes available capital is sufficient to fund current plans and obligations for at least 12 months from the filing date, but states that additional financing may be required before royalty revenue becomes meaningful.
Material Changes and Commercial Progress
- Atomera entered its first full commercial license agreement with STMicroelectronics in April 2023.
- In the fourth quarter, ST accepted Atomera’s MST film recipe, completing the first major milestone and allowing Atomera to recognize the related license revenue. ST entered Phase Four, the process-installation stage.
- ST must still complete process qualification before obtaining distribution rights and beginning potential royalty-bearing commercial shipments. There is no assurance that qualification or commercial sales will occur.
- At year-end, MST was in the integration phase for 14 engagements and in the process-installation phase for two engagements, including ST.
- Research and development spending increased materially as the company expanded outsourced fabrication, wafer processing and customer-development activity.
- Atomera lost access to TSI Technology Development & Commercialization Services’ foundry and engineering services effective January 31, 2024, after Bosch decided to convert the facility to silicon-carbide production. Replacement capacity may be difficult or costly to secure and could delay internal R&D.
- The company issued approximately 500,000 additional ATM shares after year-end at an average price of $8.08, generating approximately $3.9 million of net proceeds.
Outlook, Risks and Unusual Items
The filing provides no formal revenue, earnings or royalty guidance. Management expects continued operating losses and negative operating cash flow until commercial manufacturing and distribution licenses generate sufficient upfront fees and royalty-bearing product shipments.
- Commercialization depends on successful technical integration, process qualification and customer adoption. Semiconductor licensing cycles may take 18 to 36 months or longer.
- Revenue is highly concentrated: one customer represented 100% of 2023 revenue, and the company has generated only limited revenue since inception.
- The long-term business model depends on royalties from customer products, but no royalty-bearing commercial product shipments had been established as of the filing date.
- Atomera had an accumulated deficit of approximately $203.1 million and expects continued operating losses. Failure to obtain additional financing or commercial revenue could require reduced R&D spending or other cost reductions.
- Customer access to manufacturing tools and facilities, including leased epitaxial equipment, may be delayed or interrupted, affecting qualification timelines and costs.
- Intellectual-property protection, patent validity, potential infringement claims and enforcement of royalty rights remain material risks. The portfolio included 103 U.S. patents, 113 foreign patents and additional pending applications as of year-end.
- Macroeconomic conditions, semiconductor industry cycles, geopolitical conflicts, export controls, cybersecurity incidents and supply-chain disruptions could adversely affect operations.
- The company reported no pending material legal proceedings and no cybersecurity incident known to have materially affected the business as of the filing date.
Most Important Facts for Investors to Verify
- Whether ST completes MST process qualification, obtains distribution rights and begins commercial royalty-bearing shipments.
- Whether the 14 integration engagements and other Phase Four engagements advance to manufacturing and distribution licenses.
- The rate of cash burn, remaining ATM capacity and the timing or terms of any future equity or debt financing.
- Whether Atomera secures a replacement for TSI’s foundry and engineering services without material delays or additional costs.
- Whether MST demonstrates commercially significant performance and cost benefits at high-volume production scale.
- The degree of future dilution from the ATM facility, stock options and restricted stock awards.
- The company’s ability to diversify revenue beyond a small number of customers and generate recurring royalty income.